Avantel Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 Aug 2026 | Aerospace & Defense | Market Cap: ₹4.3K Cr
The company expects a 25% Compound Annual Growth Rate (CAGR) in sales over the next 3 years. Confident 25% CAGR growth expected for the next 3 years, with visibility unprecedented in company history.
From Avantel's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Price
₹158
Market Cap
₹4.3K Cr
P/E Ratio
247.9
Revenue Rank
Margin Rank
How does Avantel rank in Aerospace & Defense?
Compare Avantel against every Aerospace & Defense company this quarter on revenue, margins and earnings-call signals.
Avantel — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹64 Cr, net profit ₹5 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 2- →The company expects a 25% Compound Annual Growth Rate (CAGR) in sales over the next 3 years.
- →Projected revenues: ₹300 crores in the first year, ₹375-400 crores in the second, and around ₹500 crores in the third, totaling approximately ₹1,100 crores.
- →Current order book stands at about ₹1,000 crores, supporting this growth.
- →Growth to continue similarly in the 4th and 5th years, maintaining the 25% CAGR.
- →Increased R&D investments and new product lines (iDEX, SDR products, SATCOM ground stations) to drive future revenue.
- →Expansion into civilian sectors, such as fishing boats under PM’s project, contributing to diversified revenue streams.
- →The long-term plan includes reaching ₹1,000+ crores in sales, potentially scaling to ₹1,500-2,000 crores with existing infrastructure.
- →Growth depends on government policies, satellite launches, and market dynamics in defense and space sectors.
📈 Profitability & Margins
Rank 3- →Confident 25% CAGR growth expected for the next 3 years, with visibility unprecedented in company history.
- →Revenue target of ₹1,000 crores anticipated within this period, potentially scaling to ₹1,500-2,000 crores without new infrastructure.
- →EPS and return on capital employed expected to improve year-on-year over the next 3 years, assured due to existing orders and margins.
- →Profit margins vary by product mix and tender type; no specific guidance given on EBITDA margins due to competitive bidding variables.
- →2026-27 seen as an investment year with increased R&D and capital expenditure, impacting short-term profits but benefiting long-term growth.
- →Strategic plans include expansion in defense, civilian, satellite, and potentially energy sectors to sustain order continuity and scale.
- →Company maintains transparency, though sensitive financial details or order-wise margins are withheld for competitive reasons.
🏗️ Capital Expenditure Plans
Yes- →The company invested significantly in capital equipment and infrastructure to enhance capacity and address diverse market segments.
- →A new 100,000 sq. ft. R&D facility was inaugurated, predominantly for R&D activities with some production, supporting about 180 engineers.
- →Depreciation on new capital assets increased by ₹7 crores in the past year, reflecting these investments.
- →Future strategic investment considerations include exploring a strategic investor for the healthcare/Medicare division, potentially involving a majority stake sale subject to valuation and Board/shareholders approval.
- →The company is exploring diversification into the energy sector for steady order flow and larger contract opportunities.
- →Capacity expansion allows for potential revenues of ₹1,000 to ₹2,000 crores without major new infrastructure.
- →Overall, current and future capex is focused on R&D, capacity enhancement, and strategic diversification with Board and shareholder involvement.
💰 Fundraising & Capital Structure
Yes- →The company has completed its rights issue process and successfully utilized the funds as per objectives, monitored by CARE.
- →No immediate plan for fresh equity increase; assurances given that return on capital employed and EPS will improve without raising equity in the next 3 years.
- →The Board is exploring the possibility of finding a strategic investor for the healthcare/Medicare segment, which may involve selling a majority stake; this is under serious consideration but not finalized.
- →Any strategic investment will be subject to professional valuation, Board and shareholder approval, ensuring transparency.
- →Working capital limits were increased with bank support (Canara Bank, SBI), with sanctioned borrowing limits around ₹250 crores (out of approved ₹350 crores), and still have unused borrowing scope.
- →Financial management is conservative with low debt-equity (~0.1) and healthy interest coverage (approx. 11 times).
📋 Order Book & Pipeline
Yes- →Avantel Limited has a visible order book for the next 3 years, a first in the company's history.
- →The company expects a CAGR of 25% and aims to reach ₹1,000 crores revenue at the earliest in the next 3 years.
- →Orders include satellite ground stations for NSIL (Govt. of India) involving 9 units to be built over 18 months.
- →Rate contract orders worth approximately ₹460 crores, with ₹160 crores attributed to AMC over 5 years.
- →Orders include defense-related SDRs with expected market size of ₹3,000 crores/year, targeting at least 20% share.
- →Completion of current orders expected during FY 2026-27, a crucial R&D investment year.
- →Growth dependent on government policies, satellite launches, and frequency allocations.
- →Working capital and bank credit limits are adequate to support order executions.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Avantel Q4 FY26 results?
The company expects a 25% Compound Annual Growth Rate (CAGR) in sales over the next 3 years. Confident 25% CAGR growth expected for the next 3 years, with visibility unprecedented in company history.
What is Avantel share price analysis?
Avantel currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 247.9 with a market cap of ₹4,257 Cr. Investors should review the full earnings analysis for detailed insights.
Is Avantel planning capital expenditure?
The company invested significantly in capital equipment and infrastructure to enhance capacity and address diverse market segments.
Keep Avantel on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.